One study found that cutting down GSK3, a critical component of the CTNNB1 destruction complex, eliminates the inhibitory effects of HBV X protein depletion on sorafenib resistance in HCC [37], showing that canonical WNT signaling is involved in sorafenib resistance in HBV-related HCC. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.